BETAMETHASONE\MUPIROCIN: 23 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
23
Total FAERS Reports
0
Deaths Reported
14
Hospitalizations
23
As Primary/Secondary Suspect
First Report: 20180101 · Latest Report: 20180101
What Are the Most Common BETAMETHASONE\MUPIROCIN Side Effects?
#1 Most Reported
Macular degeneration
23 reports (100.0%)
#2 Most Reported
Drug ineffective
23 reports (100.0%)
#3 Most Reported
Weight decreased
14 reports (60.9%)
All BETAMETHASONE\MUPIROCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 23 | 100.0% | 0 | 14 |
| Macular degeneration | 23 | 100.0% | 0 | 14 |
| Abdominal pain | 14 | 60.9% | 0 | 14 |
| Anaemia | 14 | 60.9% | 0 | 14 |
| Chronic sinusitis | 14 | 60.9% | 0 | 14 |
| Colitis | 14 | 60.9% | 0 | 14 |
| Colitis ulcerative | 14 | 60.9% | 0 | 14 |
| Constipation | 14 | 60.9% | 0 | 14 |
| Dyspepsia | 14 | 60.9% | 0 | 14 |
| Erythema | 14 | 60.9% | 0 | 14 |
| Female genital tract fistula | 14 | 60.9% | 0 | 14 |
| Frequent bowel movements | 14 | 60.9% | 0 | 14 |
| Haematochezia | 14 | 60.9% | 0 | 14 |
| Headache | 14 | 60.9% | 0 | 14 |
| Infusion related reaction | 14 | 60.9% | 0 | 14 |
| Malaise | 14 | 60.9% | 0 | 14 |
| Nausea | 14 | 60.9% | 0 | 14 |
| Off label use | 14 | 60.9% | 0 | 14 |
| Oral candidiasis | 14 | 60.9% | 0 | 14 |
| Pain | 14 | 60.9% | 0 | 14 |
Who Reports BETAMETHASONE\MUPIROCIN Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 70.2 years. Most reports from: CA. View detailed demographics →
Is BETAMETHASONE\MUPIROCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 6 | 0 | 6 |
What Is BETAMETHASONE\MUPIROCIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 19 |
Official FDA Label for BETAMETHASONE\MUPIROCIN
Official prescribing information from the FDA-approved drug label.